AS
EVFM

Altshuler Shaham’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Altshuler Shaham’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,033
Closed -$17K – 320
2018
Q3 		$17K Hold
1,033
– – ﹤0.01% 176
2018
Q2 		$12K Buy
+1,033
New +$81.3K ﹤0.01% 146

Other funds holding EVFM

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return

Altshuler Shaham's EVFM Position: Q4 2018 in Review

Altshuler Shaham sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2018, closing a stake of 1,033 shares — an estimated $17K sold.

Altshuler Shaham first reported a position in EVFM in Q2 2018 and held it in 2 quarters. The position peaked at $17K in Q3 2018. 16 funds tracked by Wall St. Rank hold EVFM as of Q4 2018.

  • Altshuler Shaham reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Altshuler Shaham sold 1,033 Evofem Biosciences, Inc. Common Stock shares in Q4 2018, an estimated $17K.
  • Altshuler Shaham first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Altshuler Shaham's Evofem Biosciences, Inc. Common Stock position peaked at $17K in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2018.

Based on Altshuler Shaham's 13F filing for Q4 2018, filed 11 Feb 2019.